Diagnostic imaging products maker Digirad Corp. said Monday it received clearance to sell a new portable imaging system called ergo.
The system is designed to take images of the inside of a patient's body using radioactive isotopes. Digirad said the ergo system can be moved around the hospital so patients who cannot be taken to a nuclear medicine department can still be scanned. It includes a screen with a 12.5-inch-by-15.5-inch field of view.
The Food and Drug Administration issued 510(k) marketing clearance on the device. Digirad said it plans to ship the first ergo systems in June.
In morning trading, Digirad stock surged 82 cents, or 40 percent, to $2.88 and reached an annual high of $3.21 earlier.